Home page > Europe and Health | Health, wealth and equity | Health friendly research and innovation | EU Funding and programmes | Irish Presidency priorities


Please find all related articles below.

European Scientific Working Group on Influenza Flu Summit - Bringing all stakeholders on board

The second Flu Summit organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place on 23 March 2012. The event explored new concepts and ideas for bringing together all stakeholders in the fight against flu - both seasonal and pandemic. Taking off where the ESWI’s First Flu Summit wound up a year ago, the event once again brought together researchers and academics, policy-makers, NGOs, health professionals and industry representatives to debate a (...)

Save the date (June 6th)- Lunch debate on “Opening up medical research data for an ethical and efficient EU policy”

The Health Action International (HAI) Europe (1), and the Trans-Atlantic Consumer Dialogue (2) are co-ordinating a lunch debate on the subject of “Opening up medical research data for an ethical and efficient EU policy.” The debate will feature Prof. Dr. Wolf-Dieter Ludwig, Chairman at the Drug Commission of the German Medical Association, and Dr. Peter G°tzsche, Director of the Nordic Cochrane Centre as well as responses from the European Commission, the European Ombudsman and (...)

’’Recognise contribution of intensive care’’, urges MEP Buşoi at European Parliament event

On 15 May 2012, EPHA co-organised an event in collaboration with our member the European Society of Intensive Care Medicine (ESICM) at the European Parliament. Cristian Buşoi MEP (ALDE, Romania) hosted and moderated a policy debate on the contribution of ’’intensivists’’ to better patient outcomes and health systems, tied to the launch of a two-day exhibition to promote the ESCIM’s LIFE-PRIORITY campaign. The overall aim of the policy debate, entitled (...)

EMA reflection paper discusses globalisation of clinical trials

The European Medicines Agency (EMA) has published the final reflection paper on ethical and good clinical practice aspects of clinical trials of medicinal products for human use. Conducted outside of the EU/EEA and submitted in marketing authorisation, it produced several applications to the EU regulatory authorities. Entering into force on 1 May 2012, the EMA reflection paper aims to strengthen existing processes to provide assurance to regulators and stakeholders that clinical trials (...)

Civil society call for greater public return on EU health R&D spending and a turn to needs-driven innovation

HAI Europe, EPHA member, and TACD (Trans-Atlantic Consumer Dialogue) launched their new Policy Paper. The report is entitled ’Time for the EU to lead on innovation: EU policy opportunities in biomedical innovation and the creation of public knowledge goods today.’ The paper is a call for EU-funded research and development to open needs-driven innovation to support affordable access to biomedical knowledge and public goods. Read HAI and TACD paper: Time for the EU to lead on (...)

European Commission Innovation Partnership on Agricultural Productivity and Sustainability to boost European health?

On 29 February 2012, the European Commission proposed several Innovation Partnerships in order to meet key challenges facing our society, in areas that are crucial to growth and jobs: one of these be sustainable agricultural productivity. The Commission claims a more concerted innovation effort across the public and private sector of agriculture and food production, in order to improve quality of life and position Europe as a global leader. The Commission’s new European Innovation (...)

Clinical Trials Directive: A barrier to research and innovation in Europe?

EPHA member - Cancer Research UK - presents its policy recommendations to reform the Clinical Trials Directive. A new policy briefing by Cancer Research UK, ’’Supporting research, protecting patients’’ has been launched during a meeting in the European Parliament. The briefing contains a number of key recommendations to reform the Clinical Trials Directive, amongst them: option of coordinated assessment procedure for multi-national clinical trials restriction (...)

Tobacco industry attempts to undermine Framework Convention on Tobacco using the German government

Researchers at the Tobacco Control Research Group have shown in a paper published in the British Medical Journal how the Tobacco Industry attempted to use the German government to undermine the WHO Framework Convention on Tobacco Control (FCTC). Germany has been identified as one of a few high-income countries that opposed a strong Framework Convention on Tobacco Control (FCTC). A group of researchers has examined the role that the tobacco industry played in influencing the German (...)

5th European Public Health Conference - call for abstracts

The 5th European Public Health Conference will take place in Malta in November 2012. The overall theme will focus on "All Inclusive Public Health". The call for abstracts opens on the 1st of February 2012. Information on submission and deadlines is available below. The 5th European Public Health Conference aims to offer a means for exchanging information and a platform for debate to researchers, policy makers, and practitioners in the field of public health and health services research. (...)

EPHA position on the European Research Area

EPHA answered the DG Research consultation on the European Research Area. In the EPHA response, the role of CSOs and the importance of health research are highlighted. In its position, EPHA highlights the following points: Research and innovation should address the most pressing societal challenges benefiting all members of society; Energy and climate change along with population ageing and health are some of our biggest societal challenges and must be addressed by the ERA to (...)